Achaogen Stock

Achaogen EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Achaogen (AKAOQ) as of Aug 13, 2026 is -220.98 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -64.10 % — a change of 244.74% (lower).

EBIT/Assets

-220.98 %

YoY

244.74%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Achaogen is 2026 -220.98 % . Operating Income to Assets Ratio (EBIT/Assets) of Achaogen was 2025 -64.10 % . It decreases by 244.74% lower compared to the previous year.
Access this data via the Eulerpool API

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

Operating Income to Assets Ratio (EBIT/Assets) of Achaogen is -220.98 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Achaogen changed from -64.10 % to -220.98 %, representing a 244.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Achaogen since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Achaogen with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

Profitability — Achaogen

All Key Metrics — Achaogen